Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the commercial availability of NATESTO (testosterone nasal gel), the first and only nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism.
from The Medical News http://ift.tt/1AMzd9d
from The Medical News http://ift.tt/1AMzd9d
No comments:
Post a Comment